Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03718832 · ClinicalTrials.gov registry record · NA

Fresh Food Farmacy: A Randomized Controlled Trial

A NA study of Type 2 Diabetes, sponsored by John B Bulger, DO.

Completed
Registry status
NA
Development phase
500
Enrollment target
2
Study locations

NCT03718832: Completed NA study of Type 2 Diabetes, sponsored by John B Bulger, DO.

NCT03718832 is a NA study of Type 2 Diabetes that has completed, run by John B Bulger, DO. The registered enrollment target is 500 participants, below the 1,101-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (55% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03718832, a NA study of Type 2 Diabetes, has completed, sponsored by John B Bulger, DO.

COMPLETED
Registry status
NA
Development phase
500 participants
Enrollment target
2
Study locations

Study Summary

This trial investigates the value created by the highly innovative Fresh Food Farmacy (FFF) program at Geisinger Health. The program provides food-insecure diabetics with healthy food for their entire household: at least two meals per day, five days a week. The program also provides education on how to prepare the food, and education on healthy living including diabetes self management. The research measures the effects of the FFF program on patient health and wellbeing.

Conditions Studied

Interventions

  • OTHER Fresh Food Farmacy

Study Locations (2)

Pennsylvania

  • Fresh Food Farmacy - Lewistown
  • Fresh Food Farmacy - Scranton

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2019-04-22
Est. Completion 2023-11-30
Phase NA

Sponsor

John B Bulger, DO

1 total trials

What the Registry Record Tells You About NCT03718832

The ClinicalTrials.gov registry entry for NCT03718832 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,101-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (55% lower). The listed sponsor is John B Bulger, DO, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Fresh Food Farmacy is the first listed.

NCT03718832 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03718832 about?

NCT03718832 is a clinical study titled "Fresh Food Farmacy: A Randomized Controlled Trial". This trial investigates the value created by the highly innovative Fresh Food Farmacy (FFF) program at Geisinger Health. The program provides food-insecure diabetics with healthy food for their entire household: at least two meals per day, five days a week. The program also provides education on how...

What is the current status of trial NCT03718832?

This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2019-04-22. Estimated completion is 2023-11-30.

What conditions does trial NCT03718832 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT03718832?

The interventions under investigation include: Fresh Food Farmacy (OTHER).

Who is sponsoring clinical trial NCT03718832?

This trial is sponsored by John B Bulger, DO, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03718832 being conducted?

This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.